跳至主要内容
临床试验/2024-519855-27-00
2024-519855-27-00招募中4 期

N-acetylcysteine for the treatment of cannabis dependence: working mechanisms

UZ Brussel1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年1月15日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
UZ Brussel
入组人数
50
试验地点
1
主要终点
Day 14 after study start.

研究概览

简要总结

To evaluate the working mechanisms of N-acetylcysteine for the treatment of cannabis dependence

研究设计

分配方式
Randomized
主要目的
Placebo arm
盲法
Single (Subject)

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • Males, aged 18-45 years
  • Current DSM-IV diagnosis of cannabis dependence
  • >1 week detoxified and abstinent
  • Able to provide written informed consent and to comply with study procedures
  • Dutch speaking (Dutch as primary language)

排除标准

  • Currently dependent on any substance other than cannabis, alcohol or nicotine
  • History of any major internal disease (including diabetes, cardiovascular disease, lung disease, liver or kidney disease)
  • An active or any history of neurological disorder, including but not limited to seizure disorder, epilepsy, stroke, neurological disease, cognitive impairment, head trauma with prolonged loss of consciousness (>10 minutes), or migraine headaches
  • An active or a history of a psychiatric disorder including, but not limited to, depression, schizophrenia, bipolar disorder, anxiety, or other psychiatric disorders
  • Known hypersensitivity or allergy to n-acetylcysteine, or receiving chronic therapy with medication that could interact adversely with n-acetylcysteine within 30 days prior to randomization (i.e., nitroglycerin, ACE inhibitors or antihypertensive drugs, anti-coagulants)
  • Exclusion criteria for MRI: having metal in the body and/or having claustrophobia

结局指标

主要结局

Day 14 after study start.

Day 14 after study start.

次要结局

未报告次要终点

研究者

发起方
UZ Brussel
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Prof. dr. Cleo L Crunelle

Scientific

UZ Brussel

研究点 (1)

Loading locations...

相似试验